International Foundation for Functional Gastrointestinal Disorders Presents Results to FDA Advisory Committee

For Immediate Release

Media Contact form

MILWAUKEE, WI (April 23, 2002) - Today, during the FDA Advisory Committee meeting, the International Foundation for Functional Gastrointestinal Disorders (IFFGD) released the results of its IBS in the Real World survey showing the real life impact Irritable Bowel Syndrome (IBS) has on the lives of those who suffer with the disease. Results of the survey indicated substantial reduction in the quality of life and activities of daily living for patients with IBS.

IFFGD's quantitative study includes data drawn from 350 adults of the IFFGD patient database. Results of the survey reveal that nearly half of IBS sufferers polled reported daily episodes of IBS symptoms and more than one-third rated the pain associated with IBS symptoms as extreme. Additionally, more than one-quarter of survey respondents reported missing work or school due to IBS symptoms in the past three months, illustrating the challenges these patients face everyday and further highlighting the need for safe and effective treatments.

"The findings of the IBS in the Real World survey bring to light the tremendous human impact of IBS, said Nancy Norton, President and Founder of IFFGD. "Chronic and recurring symptoms of IBS can disrupt personal and professional activities, upset emotional well-being and limit individual potential, with some respondents in the survey receiving disability due to their IBS. Since there is currently no cure for IBS, it is imperative that the best ways to manage and treat this disease are made available to patients so they can enjoy a normal, active life."


Irritable bowel syndrome is a functional disease characterized by chronic and recurrent abdominal pain and abnormal bowel function. IBS sufferers have unusually sensitive and active nerve endings in the lining of the bowel that trigger inappropriate muscle activity, resulting in episodes of diarrhea, constipation, or both in alternation. The cause of IBS is not known, and as yet there is no known cure.


The survey was conducted from February 6 - March 2, 2002 with 350 patients, each of whom had previously received a diagnosis of IBS. Nearly half (47%) of IBS sufferers in the study reported daily episodes of IBS symptoms with more than one third (39%) reporting extreme or very severe pain. More than one quarter (26%) of the participants reported absenteeism from work or school due to IBS symptoms in the last three months and 5% of respondents reported being on disability due to their IBS.

IBS sufferers in the survey reported using 281 different treatments, including prescription drugs, over-the-counter (OTC) medications and herbal and dietary supplements, to control their symptoms. However, less than one-third reported satisfaction with the drugs and remedies they use to treat their symptoms. Of those taking prescription drugs, 62% report side effects, with almost half (45%) reporting the side effects as severe or moderate, thus illustrating the need for more effective treatments. Of those respondents reporting side effects:

  • 12% had to visit an ER
  • 7% were hospitalized
  • 29% had to call their health care provider, and
  • 24% had to visit their health care provider
  • 22% had to stop driving
  • 18% reported missing work or school

The survey results reveal the often hidden real world of IBS patients. More information about the survey is available online at or by calling their toll-free hotline at 1-888-964-2001.

The IFFGD is a nonprofit education and research organization whose mission it is to inform, assist and support those affected by gastrointestinal disorders. With an international group of experts from multiple disciplines who serve on the organization's medical advisory board, the IFFGD is a resource for anyone seeking current information about gastrointestinal disorders for both adults and children.



Advocacy News
Health Policy
Budget & Appropriations
Legislative Agenda
Medical Nutrition Legislation
COVID-19 Legislative Updates
Medical and Treatment News
Industry Treatment News
Medical News
Medical News - Archive (2006-2013)
Advocacy Events
Professional Meetings
Patient Education
Norton Education Series
NES Education Program
NES Program Speakers
Press Releases
2020-Gastroparesis: Quality of Life and Symptom Burdens for Patients
2020-IFFGD Announces the 2020 Research Recognition Award Winners
2020-IFFGD's IBS Patients' Illness Experience and Unmet Needs Survey
2020-IBS: More Questions Than Answers?
2020-IFFGD Raises Awareness for Rare Digestive Diseases on Rare Disease Day
2019-IFFGD recognizes December as Constipation Awareness Month with the launch of Animated Patient’s Guide to Constipation
2019-IFFGD Shares GI developments with #GivingTuesday
2019-IFFGD Celebrates 20 Years of Raising GERD Awareness
2019-IFFGD Raises Awareness for Gastroparesis Awareness Month to Encourage “Education”
2019-0516 IFFGD Announces 2019 Research Recognition Awards Recipients
2019-0328 IFFGD Encourages Patients to Share "What I Wish People Understood About My IBS" for IBS Awareness Month
2018-1205 IFFGD Marks Constipation Awareness Month with Launch of Education Campaign
2019-0213 IFFGD Sheds a Light on the Daily Impact of Rare Digestive Disorders for Rare Disease Day 2019
2018- 1107 IFFGD Celebrates #GivingTuesday
2018-1101 Have You Heard? It Could Be GERD!
2018-0801 IFFGD Raises Awareness for Gastroparesis Awareness Month to “Make Patient Voices Heard”
2018-0529 IFFGD Presents 2018 Research Recognition Awards at DDW
2018-0402 Social Taboos, Lack of Awareness May Prevent Diagnosis & Treatment of IBS
2018-0212 IFFGD Raises Awareness for Rare Disease Day 2018
2017-1114 Holiday Heartburn or Something More?
2017-0802 Research Survey Reveals Unmet Needs of People with Gastroparesis
2017-0403 IFFGD Encourages People to See Their Doctor for Symptoms of IBS
2016-1115 GERD is More Than Simple Heartburn
2016-0801 Learn the Facts About Gastroparesis
2016-0405 Think You Have IBS? Find Out For Sure Before Starting a Treatment
2015-1123 Is it More than Simple Heartburn? Ask Your Doctor.
2015-7-30 Gastroparesis is a Hidden Medical Condition for Many
2015-0330 Online Survey Looks to Help Improve Outcomes for those with IBS
2014-1119 Persistent Heartburn May Be a Sign of GERD
2014-0826 Lack of Awareness of Gastroparesis May Impact Medical Care
2014-0326 IFFGD Marks IBS Awareness Month with Launch of Mobile App
2014-0225 IFFGD Research Grants to Study Gastroparesis
2013-1106 15 Tips for GERD Awareness Week
2013-0626 New
2013-0412 IFFGD Presents 2013 Research Awards
2013-0401 Turning Attention to Returning Vets
2012-1109 Banish Frequent Heartburn by Burning More Calories
2012-0321 April is IBS Awareness Month: A Serious Issue for Veterans
2011-1130 Is Your Child's Reflux/Spitting Up A Point of Concern?
2011-0412 IFFGD Research Award Winners
2011-0329 IBS Signs You Should Not Ignore
2010-1118 GERD Difference
2010-1001 Heartburn or GERD?
2010-0517 US House Resolution for IBS
2009-1109 GERD at Night
2009-0417 IFFGD Research Award Recipients
2008-0331 Dealing with Digestive Disorders
2007-1118 When Is Simple Heartburn Not So Simple?
2007-0718 Proposed FDA Funding Applauded
2007-0401 IBS Myths
2006-1116 GERD & Holidays
2006-0418 Natl Commission
2006-0321 Women's Health
2006-0202 IBS or Something Else
2005-1125 GERD Costs
2005-0412 IBS Awareness
2004-1125 Heartburn & Heartache
2004-0929 Norton Honored
2004-0525 IBS Travel Tips
2004-0408 IBS Medical Care
2004-0101 IFFGD Conference
2003-1117 GERD Treatment
2003-0401 IFFGD Research Awards
2003-0401 IBS Awareness
2002-0423 IBS-C Treatment
2002-1102 Heartburn Caution
2002-0402 IBS & Lost Potential
2002-0423 IBS in Real World
2001-1119 Heartburn or Heart Attack
2001-0322 Patients First
1998-0401 IBS Millions Suffer
1997-1114 Research & Women's Health
Misunderstood Functional GI Disorders
IBS is No Joking Matter
For Media
Reporters' Guides
Media Contact Form

Our Mission

Education and Research

Our mission is to inform, assist and support people affected by gastrointestinal (GI) disorders.

IFFGD works with patients, families, physicians, health care professionals, and others to broaden understanding about gastrointestinal disorders and support or encourage research.

Awareness Activities & Accomplishments

Advocacy Activities

IFFGD Research Awards